AZ Health Science Centers and Divisions

Projects

Grants per year 1977 1978 1987 1989 1992 1995 1998 2002 2006 2009 2013 2021

• 5 Active
• 61 Finished
• 122 Not started

Grants per year

Search results

• Finished

  Pancreatic Ductal Adenocarcinoma Targeted Ultrasound Contrast Agent Development

  Unger, E. C.

  3/15/16 → 2/28/17

  Project: Research project

  • Contrast Media 100%
  • Adenocarcinoma 95%
  • Chronic Pancreatitis 30%
  • Survival 22%
  • Peptides 17%

• Managing chemotherapy induced neuropathy in Cancer patients using ExerGaming

  Najafi, B. & Garland, L. L.

  3/14/16 → 2/28/18

  Project: Research project

  • Peripheral Nervous System Diseases 100%
  • Drug Therapy 79%
  • Gait 68%
  • Accidental Falls 31%
  • Exercise 30%

• Pim 1 Protein Kinase in Regulating Stromal Cell Biology in Prostate Cancer

  Kraft, A.

  6/1/15 → 5/31/17

  Project: Research project

  • Prostatic Neoplasms 100%
  • Prostate 90%
  • Myofibroblasts 82%
  • Growth 72%
  • Neoplasms 52%

• Targeting the Pim 1 Protein Kinase to Overcome Resistance to AKT Inhibitors

  Kraft, A.

  9/17/13 → 7/31/18

  Project: Research project

  • Prostatic Neoplasms 100%
  • Proto-Oncogene Proteins c-pim-1 86%
  • Receptor Protein-Tyrosine Kinases 84%
  • Protein Kinases 58%
  • Neoplasms 25%

• Metformin for Reduction of Obesity Associated Breast Cancer Risk

  Chow, H.

  9/11/13 → 6/30/19

  Project: Research project

  • Metformin 100%
  • Breast Neoplasms 59%
  • Adiposity 38%
  • Weight Gain 17%
  • Breast Density 17%

• MUSC/HCC Paul Calabresi Clinical Oncology Training Program Plan

  Kraft, A. & Lilly, M.

  4/1/13 → 3/31/18

  Project: Research project

• Nsaid Effects on Clinical and Imaging Breast Biomarkers

  Stopeck, A. T. & Thompson, P.

  7/1/12 → 4/30/17

  Project: Research project

  • Aromatase Inhibitors 100%
  • Sulindac 91%
  • Breast Neoplasms 33%
  • Breast Density 26%
  • Anti-Inflammatory Agents 20%

• Development of Novel Sensitizer to Improve Response of Hypoxic Tumors to Radiatio

  Unger, E. C., Brown, J. M. & Scheck, A.

  5/24/10 → 8/31/16

  Project: Research project

  • Emulsions 100%
  • Tumor Hypoxia 70%
  • Head and Neck Neoplasms 53%
  • Neoplasms 46%
  • Radiotherapy 45%

• Novel Inhibitors of Pim Protein Kinases

  Kraft, A.

  9/7/09 → 5/31/11

  Project: Research project

  • Prostatic Neoplasms 100%
  • proto-oncogene proteins pim 99%
  • Protein Kinases 49%
  • Proto-Oncogene Proteins c-pim-1 32%
  • Capsules 32%

• Allostery and Cellular Distribution of the Nitric Oxide Recepto, Soluble...

  Briehl, M. M., Alberts, S., Adams, A., Canfield, L., Garcia, F. A., Gage, M., Weinert, T. A., Stearns, D., Ingram, J. C., Pearson, T. R., Schwartz, A., Solomon, T. G. A., Trujillo, O., Wilder, J., Briehl, M. M., Martinez, J. D., Garcia, F. A., Heimark, R. L., Harris, R. B., Gachupin, F. C., Montfort, W. R. & Kraft, A.

  9/1/09 → 8/31/19

  Project: Research project

• Clinical Study of Disposition and Biological Activity of d-Limonene

  Chow, H.

  7/17/09 → 6/30/12

  Project: Research project

  • Limonene 100%
  • perillyl alcohol 27%
  • Breast 21%
  • Breast Neoplasms 18%
  • Carcinoma, Intraductal, Noninfiltrating 11%

• Prevention of UVB-induced skin cancer using sulforaphane: roles of AP-1 and Nrf2.

  Dickinson, S. R.

  9/29/08 → 8/31/14

  Project: Research project

  • Skin Neoplasms 100%
  • sulforafan 97%
  • Transcription Factor AP-1 53%
  • Carcinogenesis 37%
  • Skin 31%

• Imaging Biomarkers for Response to Anti-Cancer Therapy

  Gillies, R. J. & Baker, V. R.

  9/1/08 → 7/31/13

  Project: Research project

• Non-Steroidal Anti-Inflammatory Drugs and Melanoma -- A Pooling Project

  Jeter, J. M.

  9/21/06 → 8/31/09

  Project: Research project

  • Melanoma 100%
  • Anti-Inflammatory Agents 73%
  • Pharmaceutical Preparations 41%
  • Health 29%
  • Chemoprevention 22%

• Breast Cancer Biomarkers for Risk and Detection (K01 Career Development Award)

  Frank, D. C.

  8/1/06 → 7/31/11

  Project: Research project

  • cancer 100%
  • biomarker 21%
  • abnormality 17%
  • trial 12%
  • didactics 10%

• DIFFUSION MRI AS BIOMARKER FOR THERAPY RESPONSE IN BREAST CANCER METASTASES

  Stopeck, A. T.

  7/14/06 → 5/30/13

  Project: Research project

  • Diffusion Magnetic Resonance Imaging 100%
  • Preliminary Data 46%
  • Biomarkers 41%
  • Breast Neoplasms 40%
  • Therapeutics 38%

• Redox-Active Agents for Pancreatic Cancer

  Dorr, R. T.

  5/1/06 → 12/31/10

  Project: Research project

  • 4-imino-1,3-diazabicyclo(3.1.0)hexan-2-one 100%
  • Pancreatic Neoplasms 60%
  • gemcitabine 47%
  • Oxidation-Reduction 27%
  • Metabolic Networks and Pathways 14%

• Pentostatin and Alemtuzumab for Allogeneic PBPCT

  Yeager, A. M.

  9/15/04 → 8/31/08

  Project: Research project

  • Pentostatin 100%
  • Alemtuzumab 91%
  • Tissue Donors 51%
  • Cell Transplantation 47%
  • Immunosuppressive Agents 36%

• Mechanisms by which Proteasome Enhance Apoptosis

  Kraft, A.

  3/1/04 → 2/28/09

  Project: Research project

  • apoptosis 100%
  • neoplasms 69%
  • neoplasm cells 49%
  • synergism 39%
  • receptors 36%

• Colorectal Screening Capacity Building Conference

  Alberts, S.

  9/1/03 → 8/31/04

  Project: Research project

  • Capacity Building 100%
  • Congresses 74%
  • Colorectal Neoplasms 29%
  • Medical Societies 24%
  • National Cancer Institute (U.S.) 21%

• SPORE in Gastrointestinal Cancer

  Roe, D., Einspahr, J. G., Bhattacharyya, A. K., Hurley, L., Nelson, M. A., Dragovich, T., Garewal, H. S., Von Hoff, D., Akporiaye, E., Mount, D., Gerner, E., Powis, G., Green, S. B. & Dvorak, K.

  9/5/02 → 3/31/15

  Project: Research project

• Sonothrombolysis of Vascular Clots with Targeted Bubbles

  Matsunaga, T. O. & Unger, E. C.

  8/15/02 → 6/30/10

  Project: Research project

  • microbubbles 100%
  • vascular diseases 61%
  • blood vessels 51%
  • therapeutics 33%
  • death 32%

• Pim 1 protein kinase as a target for drug discovery

  Kraft, A.

  4/1/02 → 3/31/06

  Project: Research project

  • Protein Kinases 100%
  • Proto-Oncogene Proteins c-pim-1 84%
  • Drug Discovery 47%
  • Carcinogenesis 35%
  • Proto-Oncogene Proteins c-mdm2 25%

• Hollings Cancer Center Planning Grant

  Kraft, A. & Reed, C.

  8/24/01 → 7/31/07

  Project: Research project

  • neoplasms 100%
  • translational medical research 13%
  • prostatic neoplasms 11%
  • rural population 11%
  • health care workers 10%

• MOLECULAR CHEMOPREVENTION MECHANISMS OF TEA POLYPHENOLS

  Stratton, S. P.

  8/1/00 → 7/31/05

  Project: Research project

  • Polyphenol 100%
  • Chemopreventive 54%
  • Green 39%
  • Marker 33%
  • Stevens Reaction 30%

• DIFFUSION MRI AND CHEMOTHERAPEUTIC RESPONSE

  Stopeck, A. T.

  8/1/00 → 7/31/03

  Project: Research project

  • Diffusion Magnetic Resonance Imaging 100%
  • Water 56%
  • Drug Therapy 33%
  • Docetaxel 31%
  • Therapeutics 18%

• PHASE III TRIAL OF SELENIUM FOR PROSTATE CANCER PREVENT

  Ahmann, F. R. & Marshall, J.

  9/30/99 → 10/31/11

  Project: Research project

  • Prostatic Neoplasms 100%
  • Selenium 70%
  • Prostate-Specific Antigen 21%
  • Incidence 20%
  • Placebos 14%

• DIRECT NOSE/BRAIN DRUG/PEPTIDE TRANSPORT

  Chow, H.

  4/10/99 → 3/31/02

  Project: Research project

  • Nasal Cavity 100%
  • Brain 86%
  • Nose 71%
  • Peptides 65%
  • Pharmaceutical Preparations 42%

• PHASE II CHEMOPREVENTION TRIAL OF SE AND PROSTATE CANCER

  Ahmann, F. R., Marshall, J. & Clark, L.

  9/30/98 → 8/31/09

  Project: Research project

• PHASE I CLINICAL STUDIES OF POLYPHENOLS

  Alberts, S.

  9/30/98 → 9/29/01

  Project: Research project

  • Pharmacokinetics 100%
  • Healthy Volunteers 88%
  • epigallocatechin gallate 84%
  • Safety 77%
  • Polyphenols 73%

• REGULATION OF PROSTATE CANCER PROGRAMMED CELL DEATH

  Kraft, A.

  8/14/98 → 4/30/03

  Project: Research project

  • prostatic neoplasms 100%
  • apoptosis 77%
  • androgens 52%
  • neoplasm cells 28%
  • programmed cell death 23%

• CANCER PREVENTION AND CONTROL TRAINING GRANT

  Alberts, S., Marshall, J., Kittles, R. A., Harris, R. B., Harris, R. B. & Alberts, S.

  7/1/98 → 8/31/16

  Project: Research project

  • neoplasms 100%
  • public health 22%
  • mentoring 18%
  • uterine cervical neoplasms 16%
  • skin neoplasms 16%

• BRYOSTATIN 1 THERAPY OF METASTATIC MELANOMA

  Kraft, A.

  9/15/95 → 8/31/98

  Project: Research project

  • bryostatin 1 100%
  • Melanoma 33%
  • Protein Kinase C 12%
  • Bryostatins 11%
  • Pharmacology 8%

• DIFFERENTIATION THERAPY OF CHRONIC MYELOGENOUS LEUKEMIA

  Kraft, A.

  4/25/95 → 3/31/97

  Project: Research project

  • bryostatin 1 100%
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive 12%
  • Appointments and Schedules 9%
  • Hematopoietic System 7%
  • Lactones 7%

• PHOENIX LEADERSHIP MINI-SUMMIT

  Alberts, S.

  9/10/93 → 9/9/95

  Project: Research project

  • National Cancer Institute (U.S.) 100%
  • Breast Neoplasms 91%
  • Workplace 83%
  • Hispanic Americans 82%
  • Education 72%

• PROSTATE CARCINOMA--INVASION AND METASTASIS FACTORS

  Cress, A. E., Gandolfi, A. J., Nagle, R. B., Heimark, R. L., Cress, A. E., Payne, C., Bellamy, W., Bowden, G., Grogan, T., Vaillancourt, R., Payne, C. M. & Bellamy, W.

  5/14/93 → 3/31/10

  Project: Research project

• CLINICAL ONCOLOGY RESEARCH TRAINING

  Hersh, E. M. & Taetle, R.

  9/24/92 → 8/31/98

  Project: Research project

  • cancer 100%
  • training program 65%
  • trainee 50%
  • physician 41%
  • expertise 40%

• CYTOKINE REGULATION OF CHOLESTEROL TRAFFICKING

  Stopeck, A. T.

  7/1/92 → 6/30/98

  Project: Research project

  • Cholesterol 100%
  • LDL Receptors 52%
  • Cytokines 42%
  • Atherosclerosis 36%
  • Liver 35%

• FOURTH INTERNATIONAL CONFERENCE ON CANCER &NUTRITION

  Alberts, S.

  6/4/92 → 5/31/93

  Project: Research project

  • Congresses 100%
  • Neoplasms 65%
  • Chemoprevention 56%
  • Vitamins 50%
  • Tertiary Prevention 37%

• MECHANISM OF ACTION OF GM-CSF

  Kraft, A.

  3/1/92 → 11/30/01

  Project: Research project

  • Granulocyte-Macrophage Colony-Stimulating Factor 100%
  • Granulocyte-Macrophage Colony-Stimulating Factor Receptors 22%
  • Genetic Enhancer Elements 18%
  • Growth 18%
  • Genes 17%

• IMMUNOPHARMACOLOGIC ERADICATION OF MYELOID LEUKEMIA

  Yeager, A. M.

  2/20/92 → 11/30/98

  Project: Research project

  • myeloid leukemia 100%
  • bone marrow transplant 24%
  • cells 17%
  • leukemia 10%
  • stem cells 10%

• TUCSON LEADERSHIP SUMMIT--THE CHALLENGE OF BREAST CANCER

  Alberts, S.

  1/31/92 → 6/30/93

  Project: Research project

  • Breast Neoplasms 100%
  • Workplace 75%
  • Hispanic Americans 75%
  • National Cancer Institute (U.S.) 60%
  • Organizations 43%

• CANCER ETIOLOGY AND PREVENTION

  Alberts, S., Moon, T. & Ritenbaugh, C.

  6/1/90 → 2/28/03

  Project: Research project

• HUMAN MONOCLONAL ANTIBODIES TO HIV

  Hersh, E. M.

  12/1/89 → 11/30/92

  Project: Research project

  • Monoclonal Antibodies 100%
  • HIV 56%
  • HIV Antibodies 52%
  • Antibody-Dependent Cell Cytotoxicity 37%
  • Epitopes 35%

• LIPOSOMAL CONTRAST AGENTS FOR MR IMAGING

  Unger, E. C.

  9/30/89 → 2/28/93

  Project: Research project

  • magnetic resonance imaging 100%
  • image analysis 61%
  • neoplasms 57%
  • reticuloendothelial system 36%
  • scintigraphy 36%

• CANCER CENTER CORE GRANT

  Kraft, A., Braun, T., Mmaller, J., Hirs, W. C., Scoggin, C., Hendrick, E., Archer, P., Patterson, D., Miller, G., Schmeler, R., Kolhouse, F., Johnston, M., Krebs, L., Talmage, D., Johnson, G., Jones, D. N., Pfenninger, K., Irons, R., Garcea, R., Cole, W., Kavanagh, B., Williams, T., Bondy, J., Ullrich, R., Tran, Z., Gutierrez-Hartmann, A., Geraci, M., Varella-Garcia, M., Kane, M., Duncan, M., Bellgrau, D., Elias, A., Marcus, A. L., Reardon, C., Anderson, S., Eckhardt, S. G., Gustafson, D., Holt, J., Sclafani, R., Miller, Y., Churchill, M., Byers, T., Theodorescu, D. A. N., Marcus, A., Hendrick, R., Duke, R., McManaman, J. L., McHenry, C., Murphy, J. R., Gemmill, R., Bearman, S., Franklin, W., Bunn, P., Edwards, D., Drabkin, H. A. & Stevens, J.

  3/1/88 → 1/31/17

  Project: Research project

• DRUG DISCOVERY GROUP FOR THE TREATMENT OF AIDS

  Hersh, E. M., Shannon, W., Stephens, E. B. & Chirigos, M.

  9/30/87 → 9/30/94

  Project: Research project

  • Drug Discovery 100%
  • Biomedical Research 78%
  • Acquired Immunodeficiency Syndrome 64%
  • Preclinical Drug Evaluations 46%
  • Contracts 45%

• TRANSPLANT STUDIES IN GLOBOID CELL LEUKODYSTROPHY

  Yeager, A. M.

  4/1/87 → 12/31/96

  Project: Research project

  • cell transplantation 100%
  • mice 30%
  • spinal cord 16%
  • brain 15%
  • enzyme replacement therapy 13%

• EX VIVO PHARMACOLOGIC PURGING IN LEUKEMIA

  Yeager, A. M.

  1/1/87 → 11/30/98

  Project: Research project

• CYTOGENETIC ONCOLOGY PROGRAM PROJECT

  Alberts, S., Leibovitz, A., Meyskens, F., Moon, T., Meltzer, P., Vogelstein, B., Dalton, W., Sandberg, A., McGee, D., Davis, J., Trent, J., Salmon, S. & Taetle, R.

  1/1/87 → 5/31/96

  Project: Research project